Xia Chen
- Nephrology top 1%
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 12
- Periodontics top 2%
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies 4
-
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Gut microbiota and health 8
-
- MicroRNA in disease regulation 5
-
- Ophthalmology and Eye Disorders 5
-
- Chronic Lymphocytic Leukemia Research 4
-
- Diabetes Treatment and Management 4
- Co-authors
- Kiyoshi MoriKai M. Schmidt‐OttJonathan BaraschJaya MishraKirk FosterCheryl L. KunisPrasad DevarajanFaisal H. Cheema
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xia Chen
130 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Nephrology 583
- Molecular Medicine 204
- Critical Care and Intensive Care Medicine 202
- Periodontics 170
- Obstetrics and Gynecology 164
Countries citing papers authored by Xia Chen
This map shows the geographic impact of Xia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Chen more than expected).
Fields of papers citing papers by Xia Chen
This network shows the impact of papers produced by Xia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Chen. The network helps show where Xia Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xia Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 69 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 31 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 17 | |
| 15 | 2019 | 39 | |
| 16 | 2015 | 41 | |
| 17 | Economic Consideration of the Assisted Reproductive Technology | 2014 | 1 |
| 18 | 2014 | 14 | |
| 19 | 2014 | 19 | |
| 20 | 2009 | 38 |
About Xia Chen
Xia Chen is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Microbiology, having authored 137 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Gut microbiota and health (8 papers), MicroRNA in disease regulation (5 papers), Ophthalmology and Eye Disorders (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Diabetes Treatment and Management (4 papers) and Pregnancy and preeclampsia studies (4 papers). The work is most often cited by research in Nephrology (583 citations), Molecular Medicine (204 citations) and Critical Care and Intensive Care Medicine (202 citations). Xia Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Kiyoshi Mori, Kai M. Schmidt‐Ott, Jonathan Barasch, Jaya Mishra, Kirk Foster, Cheryl L. Kunis, Prasad Devarajan, Faisal H. Cheema, Vivette D. D’Agati and Masashi Mukoyama. Their work appears in journals such as Clinical Therapeutics, Gut, Acta Pharmacologica Sinica, Frontiers in Neurology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.